Search by Drug Name or NDC
NDC 66215-0616-06 UPTRAVI 1600 ug/1 Details
UPTRAVI 1600 ug/1
UPTRAVI is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actelion Pharmaceuticals US, Inc.. The primary component is SELEXIPAG.
MedlinePlus Drug Summary
Selexipag is used in adults to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs) to slow down the worsening of symptoms and reduce the chance of being hospitalized for PAH. Selexipag is in a class of medications called selective nonprostanoid IP prostacyclin receptor agonists. It works by relaxing the blood vessels in the lungs to allow blood to flow easily.
Related Packages: 66215-0616-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Selexipag
Product Information
| NDC | 66215-0616 |
|---|---|
| Product ID | 66215-616_f9b62ce2-37c1-2e5c-e053-6394a90a657b |
| Associated GPIs | 40120070000345 |
| GCN Sequence Number | 075319 |
| GCN Sequence Number Description | selexipag TABLET 1600 MCG ORAL |
| HIC3 | B1C |
| HIC3 Description | PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE |
| GCN | 40376 |
| HICL Sequence Number | 042922 |
| HICL Sequence Number Description | SELEXIPAG |
| Brand/Generic | Brand |
| Proprietary Name | UPTRAVI |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Selexipag |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 1600 |
| Active Ingredient Units | ug/1 |
| Substance Name | SELEXIPAG |
| Labeler Name | Actelion Pharmaceuticals US, Inc. |
| Pharmaceutical Class | Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA207947 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66215-0616-06 (66215061606)
| NDC Package Code | 66215-616-06 |
|---|---|
| Billing NDC | 66215061606 |
| Package | 1 BOTTLE in 1 CARTON (66215-616-06) / 60 TABLET, COATED in 1 BOTTLE |
| Marketing Start Date | 2015-12-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |